Loading clinical trials...
Loading clinical trials...
Present imaging modalities for primary liver cancer (hepatocellular carcinoma or HCC) have several shortcomings. One important shortcoming is the time delay between successful treatment and radiologic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Ghent
Collaborators
NCT07466602 · Primary Liver Cancer
NCT06914648 · Primary Liver Cancer, Hepatocellular Carcinoma (HCC), and more
NCT06766643 · Primary Liver Cancer
NCT06430983 · Recurrent Liver Cancer, Primary Liver Cancer
NCT04806464 · Primary Liver Cancer
University Hospital Ghent
Ghent
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions